Contact Us
Chikungunya Global Market Report 2025
Global Chikungunya Market Report 2025
Item added to cart!

Published : December 2025

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Chikungunya Global Market Report 2025

By Type (Antiviral Drugs, Herbal And Complementary Treatments, Supportive Care, Vaccines), By Product Form (Liquid Form, Powder, Solid Form), By Disease Stage (Acute, Chronic, Post-Infection), By Sales Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Supermarkets), By End User (Caregivers, Healthcare Professionals, Patients) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Chikungunya Market Overview

• Chikungunya market size has reached to $0.59 billion in 2024

• Expected to grow to $0.92 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%

• Growth Driver: Increasing Global Incidence Of Mosquito-Borne Diseases Driving Market Growth

• Market Trend: Innovative Chikungunya Vaccines Advancing Immunity And Disease Prevention

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Chikungunya Market?

Chikungunya (CHIKV) is a viral infection caused by the chikungunya virus, primarily transmitted to humans through the bites of infected Aedes aegypti and Aedes albopictus mosquitoes. The virus causes fever, joint pain, headache, rash, and muscle pain, significantly impacting the quality of life of affected individuals.

The main product types for chikungunya include antiviral drugs, herbal and complementary treatments, supportive care, and vaccines. Antiviral drugs are medications designed to prevent or treat viral infections by inhibiting the replication of viruses in the body. These products are available in various forms, such as liquid, powder, and solid forms. These are applied at different stages of the disease, including acute, chronic, and post-infection stages. These are distributed through multiple sales channels, including hospital pharmacies, online pharmacies, retail pharmacies, and supermarkets and are used by various end users such as caregivers, healthcare professionals, and patients.

Chikungunya Market Size and growth rate 2025 to 2029: Graph

What Is The Chikungunya Market Size 2025 And Growth Rate?

The chikungunya market size has grown strongly in recent years. It will grow from $0.59 billion in 2024 to $0.65 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to increasing per capita healthcare expenditures, growing prevalence of emerging and re-emerging infectious diseases, increasing personal disposable income, climate change, and increasing awareness regarding mosquito disease.

What Is The Chikungunya Market Growth Forecast?

The chikungunya market size is expected to see strong growth in the next few years. It will grow to $0.92 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to an international boost in clinical trials, a growing geriatric population, a rising need for immunization, increasing government and non-government initiatives, increasing government investments, and favorable policies. Major trends in the forecast period include advancements in biotechnology for vaccine development, new vaccine opportunities, CRISPR and AI for innovative solutions, strategic collaborations among pharmaceutical players, and integration of telemedicine services.

The forecast of 9.2% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose challenges for U.S. tropical medicine by restricting access to rapid diagnostic tests and antiviral medications imported from Brazil and Singapore, potentially delaying outbreak responses and increasing public health expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Chikungunya Market Segmented?

1) By Type: Antiviral Drugs, Herbal And Complementary Treatments, Supportive Care, Vaccines

2) By Product Form: Liquid Form, Powder, Solid Form

3) By Disease Stage: Acute, Chronic, Post-Infection

4) By Sales Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Supermarkets

5) By End User: Caregivers, Healthcare Professionals, Patients

Subsegments:

1) By Antiviral Drugs: Nucleoside Analogues, Protease Inhibitors

2) By Herbal And Complementary Treatments: Ayurvedic Remedies, Homeopathic Treatments, Traditional Chinese Medicine

3) By Supportive Care: Pain Relievers (NSAIDs, Acetaminophen), Fluid Therapy, Physiotherapy

4) By Vaccines: Live-Attenuated Vaccines, inactivated vaccines, mRNA-Based Vaccines

What Is Driving The Chikungunya Market? Increasing Global Incidence Of Mosquito-Borne Diseases Driving Market Growth

The rising prevalence of mosquito-borne diseases is expected to propel the growth of the chikungunya market going forward. Mosquito-borne diseases, such as chikungunya, dengue, and zika virus, are transmitted to humans by infected aedes mosquitoes and pose significant public health challenges globally. The rising global incidence of mosquito-borne diseases is due to climate change, urbanization, deforestation, stagnant water accumulation, inadequate vector control measures, increased global travel, and insecticide resistance. Chikungunya treatment supports mosquito-borne disease patients by alleviating symptoms such as fever, joint pain, and inflammation, improving overall comfort and mobility, reducing the risk of complications, and enhancing recovery through hydration, pain management, and supportive care. For instance, in December 2024, according to the UK Health Security Agency, a UK-based government agency, Between January and June 2024, reported dengue cases among returning travelers in England, Wales, and Northern Ireland surged to 473, marking a 201% increase compared to the 157 cases recorded during the same period in 2023. Therefore, the increasing global incidence of mosquito-borne diseases is driving the growth of the chikungunya industry.

Who Are The Major Players In The Global Chikungunya Market?

Major companies operating in the chikungunya market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Quest Diagnostics Incorporated, Eurofins Scientific SE, Grifols Diagnostic Solutions Inc., bioMérieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Euroimmun AG, Evotec SE, Valneva SE, ELITechGroup S.A.S., Vaxart Inc., BioPerfectus Biotechnology Co. Ltd., CTK Biotech Inc., Creative Diagnostics Inc., Inovio Pharmaceuticals Inc., Biotrol Laboratories Pvt. Ltd.

What Are The Key Trends Of The Global Chikungunya Market? Innovative Chikungunya Vaccines Advancing Immunity And Disease Prevention

Major companies operating in the chikungunya market are focusing on developing innovative vaccines to enhance immunity, prevent disease outbreaks, and address the growing global health burden of chikungunya virus infections. A live attenuated chikungunya vaccine is a vaccine that uses a weakened form of the chikungunya virus to stimulate an immune response without causing the disease, providing long-lasting protection. For instance, in November 2023, Valneva SE, a France-based biotechnology company announced IXCHIQ, a live attenuated chikungunya vaccine approved by the Food and Drug Administration (FDA), a US-based government agency. This approval was made under accelerated approval based on anti-CHIKV neutralizing antibody titers, with continued approval contingent upon verification of clinical benefit in confirmatory studies. Valneva received a Priority Review Voucher (PRV) from the FDA, which the company intends to monetize to help finance its research and development programs. Ixchiq is given as a single-dose injection into the muscle and contains a live, weakened form of the chikungunya virus, which may cause symptoms in recipients similar to those of chikungunya disease.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Chikungunya Market? Bavarian Nordic A/S Acquires Travel Vaccine Portfolio from Emergent BioSolutions Inc. Expanding Presence in Market

In February 2023, Bavarian Nordic A/S, a Denmark-based biotechnology company acquired travel vaccines from Emergent BioSolutions Inc. for USD 380 million. With this acquisition, Bavarian Nordic A/S aims to strengthen its position in the travel vaccine by acquiring marketed travel vaccines including Vivotif for the prevention of typhoid fever, Vaxchora for cholera along with a phase 3 vaccine candidate for the prevention of chikungunya virus. Emergent BioSolutions Inc. is a US-based life sciences company that offers chikungunya vaccines.

What Is The Regional Outlook For The Global Chikungunya Market?

North America was the largest region in the chikungunya market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Chikungunya  Market?

The chikungunya market consists of revenues earned by entities by providing services such as vaccination services, diagnostic testing services, and consultation and medical care. The market value includes the value of related goods sold by the service provider or included within the service offering. The chikungunya market also includes sales of vaccines, diagnostic kits, supportive therapies, and diagnostic equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Chikungunya  Industry?

The chikungunya market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the chikungunya industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Chikungunya Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $0.65 billion
Revenue Forecast In 2034 $0.92 billion
Growth Rate CAGR of 9.2% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The chikungunya market covered in this report is segmented –
1) By Type: Antiviral Drugs, Herbal And Complementary Treatments, Supportive Care, Vaccines
2) By Product Form: Liquid Form, Powder, Solid Form
3) By Disease Stage: Acute, Chronic, Post-Infection
4) By Sales Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Supermarkets
5) By End User: Caregivers, Healthcare Professionals, Patients Subsegments:
1) By Antiviral Drugs: Nucleoside Analogues, Protease Inhibitors
2) By Herbal And Complementary Treatments: Ayurvedic Remedies, Homeopathic Treatments, Traditional Chinese Medicine
3) By Supportive Care: Pain Relievers (NSAIDs, Acetaminophen), Fluid Therapy, Physiotherapy
4) By Vaccines: Live-Attenuated Vaccines, Inactivated Vaccines, mRNA-Based Vaccines
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Quest Diagnostics Incorporated, Eurofins Scientific SE, Grifols Diagnostic Solutions Inc., bioMérieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Euroimmun AG, Evotec SE, Valneva SE, ELITechGroup S.A.S., Vaxart Inc., BioPerfectus Biotechnology Co. Ltd., CTK Biotech Inc., Creative Diagnostics Inc., Inovio Pharmaceuticals Inc., Biotrol Laboratories Pvt. Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Chikungunya Market Characteristics

3. Chikungunya Market Trends And Strategies

4. Chikungunya Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Chikungunya Growth Analysis And Strategic Analysis Framework

5.1. Global Chikungunya PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Chikungunya Market Growth Rate Analysis

5.4. Global Chikungunya Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Chikungunya Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Chikungunya Total Addressable Market (TAM)

6. Chikungunya Market Segmentation

6.1. Global Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antiviral Drugs

Herbal And Complementary Treatments

Supportive Care

Vaccines

6.2. Global Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Liquid Form

Powder

Solid Form

6.3. Global Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Acute

Chronic

Post-Infection

6.4. Global Chikungunya Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Supermarkets

6.5. Global Chikungunya Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Caregivers

Healthcare Professionals

Patients

6.6. Global Chikungunya Market, Sub-Segmentation Of Antiviral Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Nucleoside Analogues

Protease Inhibitors

6.7. Global Chikungunya Market, Sub-Segmentation Of Herbal And Complementary Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Ayurvedic Remedies

Homeopathic Treatments

Traditional Chinese Medicine

6.8. Global Chikungunya Market, Sub-Segmentation Of Supportive Care, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pain Relievers (NSAIDs, Acetaminophen)

Fluid Therapy

Physiotherapy

6.9. Global Chikungunya Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Live-Attenuated Vaccines

Inactivated Vaccines

mRNA-Based Vaccines

7. Chikungunya Market Regional And Country Analysis

7.1. Global Chikungunya Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Chikungunya Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Chikungunya Market

8.1. Asia-Pacific Chikungunya Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Chikungunya Market

9.1. China Chikungunya Market Overview

9.2. China Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Chikungunya Market

10.1. India Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Chikungunya Market

11.1. Japan Chikungunya Market Overview

11.2. Japan Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Chikungunya Market

12.1. Australia Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Chikungunya Market

13.1. Indonesia Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Chikungunya Market

14.1. South Korea Chikungunya Market Overview

14.2. South Korea Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Chikungunya Market

15.1. Western Europe Chikungunya Market Overview

15.2. Western Europe Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Chikungunya Market

16.1. UK Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Chikungunya Market

17.1. Germany Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Chikungunya Market

18.1. France Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Chikungunya Market

19.1. Italy Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Chikungunya Market

20.1. Spain Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chikungunya Market

21.1. Eastern Europe Chikungunya Market Overview

21.2. Eastern Europe Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Chikungunya Market

22.1. Russia Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Chikungunya Market

23.1. North America Chikungunya Market Overview

23.2. North America Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Chikungunya Market

24.1. USA Chikungunya Market Overview

24.2. USA Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Chikungunya Market

25.1. Canada Chikungunya Market Overview

25.2. Canada Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Chikungunya Market

26.1. South America Chikungunya Market Overview

26.2. South America Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Chikungunya Market

27.1. Brazil Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Chikungunya Market

28.1. Middle East Chikungunya Market Overview

28.2. Middle East Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Chikungunya Market

29.1. Africa Chikungunya Market Overview

29.2. Africa Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Chikungunya Market Competitive Landscape And Company Profiles

30.1. Chikungunya Market Competitive Landscape

30.2. Chikungunya Market Company Profiles

30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Chikungunya Market Other Major And Innovative Companies

31.1. Eurofins Scientific SE

31.2. Grifols Diagnostic Solutions Inc.

31.3. bioMérieux SA

31.4. Bio-Rad Laboratories Inc.

31.5. DiaSorin S.p.A.

31.6. Euroimmun AG

31.7. Evotec SE

31.8. Valneva SE

31.9. ELITechGroup S.A.S.

31.10. Vaxart Inc.

31.11. BioPerfectus Biotechnology Co. Ltd.

31.12. CTK Biotech Inc.

31.13. Creative Diagnostics Inc.

31.14. Inovio Pharmaceuticals Inc.

31.15. Biotrol Laboratories Pvt. Ltd.

32. Global Chikungunya Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chikungunya Market

34. Recent Developments In The Chikungunya Market

35. Chikungunya Market High Potential Countries, Segments and Strategies

35.1 Chikungunya Market In 2029 - Countries Offering Most New Opportunities

35.2 Chikungunya Market In 2029 - Segments Offering Most New Opportunities

35.3 Chikungunya Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Chikungunya Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Chikungunya Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Chikungunya Market, Sub-Segmentation Of Antiviral Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Chikungunya Market, Sub-Segmentation Of Herbal And Complementary Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Chikungunya Market, Sub-Segmentation Of Supportive Care, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Chikungunya Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Chikungunya Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Chikungunya Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 81: Merck & Co. Inc. Financial Performance
  • Table 82: Thermo Fisher Scientific Inc. Financial Performance
  • Table 83: Takeda Pharmaceutical Company Limited Financial Performance
  • Table 84: Quest Diagnostics Incorporated Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Chikungunya Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Chikungunya Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Chikungunya Market, Sub-Segmentation Of Antiviral Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Chikungunya Market, Sub-Segmentation Of Herbal And Complementary Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Chikungunya Market, Sub-Segmentation Of Supportive Care, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Chikungunya Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Chikungunya Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Chikungunya Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Chikungunya Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Chikungunya Market, Segmentation By Product Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Chikungunya Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 81: Merck & Co. Inc. Financial Performance
  • Figure 82: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 83: Takeda Pharmaceutical Company Limited Financial Performance
  • Figure 84: Quest Diagnostics Incorporated Financial Performance

Frequently Asked Questions

Chikungunya (CHIKV) is a viral infection caused by the chikungunya virus, primarily transmitted to humans through the bites of infected Aedes aegypti and Aedes albopictus mosquitoes. The virus causes fever, joint pain, headache, rash, and muscle pain, significantly impacting the quality of life of affected individuals. For further insights on this market, request a sample here

The market major growth driver - Increasing Global Incidence Of Mosquito-Borne Diseases Driving Market Growth. For further insights on this market, request a sample here

The chikungunya market size has grown strongly in recent years. It will grow from $0.59 billion in 2024 to $0.65 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to increasing per capita healthcare expenditures, growing prevalence of emerging and re-emerging infectious diseases, increasing personal disposable income, climate change, and increasing awareness regarding mosquito disease. The chikungunya market size is expected to see strong growth in the next few years. It will grow to " $0.92 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to an international boost in clinical trials, a growing geriatric population, a rising need for immunization, increasing government and non-government initiatives, increasing government investments, and favorable policies. Major trends in the forecast period include advancements in biotechnology for vaccine development, new vaccine opportunities, CRISPR and AI for innovative solutions, strategic collaborations among pharmaceutical players, and integration of telemedicine services. For further insights on this market, request a sample here

The chikungunyamarket covered in this report is segmented –
1) By Type: Antiviral Drugs; Herbal And Complementary Treatments; Supportive Care; Vaccines
2) By Product Form: Liquid Form; Powder; Solid Form
3) By Disease Stage: Acute; Chronic; Post-Infection
4) By Sales Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies; Supermarkets
5) By End User: Caregivers; Healthcare Professionals; Patients Subsegments:
1) By Antiviral Drugs: Nucleoside Analogues; Protease Inhibitors
2) By Herbal And Complementary Treatments: Ayurvedic Remedies; Homeopathic Treatments; Traditional Chinese Medicine
3) By Supportive Care: Pain Relievers (NSAIDs, Acetaminophen); Fluid Therapy; Physiotherapy
4) By Vaccines: Live-Attenuated Vaccines; Inactivated Vaccines; mRNA-Based Vaccines For further insights on this market,
request a sample here

North America was the largest region in the chikungunya market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chikungunya market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the chikungunya market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Quest Diagnostics Incorporated, Eurofins Scientific SE, Grifols Diagnostic Solutions Inc., bioMérieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Euroimmun AG, Evotec SE, Valneva SE, ELITechGroup S.A.S., Vaxart Inc., BioPerfectus Biotechnology Co. Ltd., CTK Biotech Inc., Creative Diagnostics Inc., Inovio Pharmaceuticals Inc., Biotrol Laboratories Pvt. Ltd. . For further insights on this market, request a sample here.

Major trends in this market include Innovative Chikungunya Vaccines Advancing Immunity And Disease Prevention. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon